TARGET-I, NCT02197169: DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors |
|
|
| Completed | 1b | 37 | US | Single intratumoral injection of DNX-2401, Oncolytic virus, Genetically-modified adenovirus, Interferon-gamma, Actimmune, immunotherapy, gamma interferon | DNAtrix, Inc. | Glioblastoma or Gliosarcoma | 03/18 | 03/18 | | |
NCT03896568: MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma |
|
|
| Recruiting | 1 | 36 | US | Oncolytic Adenovirus Ad5-DNX-2401, Ad5-Delta24RGD, DNX-2401, DNX2401, Oncolytic Ad5-Delta 24RGD, Oncolytic Adenovirus Ad5-Delta 24RGD, Therapeutic Conventional Surgery | M.D. Anderson Cancer Center, DNAtrix, Inc. | IDH1 wt Allele, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Malignant Glioma | 09/27 | 09/27 | | |
